<DOC>
	<DOCNO>NCT02369250</DOCNO>
	<brief_summary>Rosuvastatin ( RSV ) new synthetic , second-generation , sulfur-containing , hydrophilic statin , stimulate bone formation critical-size cortical bone defect adjacent titanium implant , administer locally bone . Platelet-rich fibrin ( PRF ) platelet concentrate sustain release various growth factor , regenerative potential treat periodontal defect . Porous hydroxyapatite ( HA ) bone graft material clinically satisfactory response , use fill periodontal intrabony defect . This double-masked randomized study design evaluate potency combination RSV 1.2mg situ gel 1:1 mixture autologous PRF HA bone graft surgical treatment mandibular degree II furcation defect compare autologous PRF HA bone graft place open flap debridement ( OFD ) .</brief_summary>
	<brief_title>Rosuvastatin Gel With 1:1 Mixture Platelet-rich Fibrin Bone Graft Mandibular Degree II Furcation Defects</brief_title>
	<detailed_description>ABSTRACT Background : A wide range regenerative material try treatment furcation defect . Rosuvastatin ( RSV ) new synthetic , second-generation , sulfur-containing , hydrophilic statin , stimulate bone formation critical-size cortical bone defect adjacent titanium implant , administer locally bone . Platelet-rich fibrin ( PRF ) platelet concentrate sustain release various growth factor , regenerative potential treat periodontal defect . Porous hydroxyapatite ( HA ) bone graft material clinically satisfactory response , use fill periodontal intrabony defect . This double-masked randomized study design evaluate potency combination RSV 1.2mg situ gel 1:1 mixture autologous PRF HA bone graft surgical treatment mandibular degree II furcation defect compare autologous PRF HA bone graft place open flap debridement ( OFD ) . Material method 105 patient mandibular buccal Class II furcation defect randomly allot treated either , OFD placebo gel : Group 1 , OFD + autologous PRF porus-HA bone graft : Group 2 , OFD + RSV 1.2mg situ gel combine autologous PRF porus-HA bone graft : Group 3 . Clinical parameter record baseline SRP 9 month ; include modified sulcus bleed index ( mSBI ) , probe depth ( PD ) , relative vertical ( RVAL ) horizontal ( RHAL ) attachment level . At baseline 9 month , radiographic assessment bone defect fill perform postoperatively .</detailed_description>
	<mesh_term>Furcation Defects</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>1. presence buccal Class II furcation defect endodontically vital , asymptomatic mandibular first second molar radiolucency furcation area intraoral periapical radiograph PD ± 5mm horizontal PD ± 3mm Phase I therapy ( SRP ) 2. history antibiotic periodontal therapy precede 6 month . 1. systemic illness know affect outcome periodontal therapy , diabetes mellitus , cardiac disease , insufficient platelet count ( &lt; 200,000/mm3 ) , immunocompromised ( e.g. , HIV individual ) patient take medication , corticosteroid calcium channel blocker , know interfere periodontal wind heal 2. individual know suspect allergy RSV group allergic medication 3. systemic statin therapy 4. pregnant lactate woman 5. patient use tobacco form 6. individual unacceptable oral hygiene ( plaque index &gt; 1.5 ) . In addition , teeth interproximal intrabony defect , gingival recession , endodontic ( pulpal ) involvement , mobility tooth ≥ Grade II also exclude .</criteria>
	<gender>All</gender>
	<minimum_age>26 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>regeneration</keyword>
	<keyword>surgical therapy</keyword>
	<keyword>furcation defect</keyword>
</DOC>